Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

3M & Verily Collaborate For New Technology, Shares Flat

Published 10/12/2016, 09:17 PM
Updated 07/09/2023, 06:31 AM

3M Health Information Systems, a joint venture between 3M Company (NYSE:MMM) and Verily Life Sciences, recently entered into a strategic agreement to jointly develop a new population health measurement technology to enhance clinical and financial performance. Following the announcement, the company’s shares remained relatively flat to close at $169.72 on Oct 12.

Verily (formerly Google Life Sciences) is a bio research and engineering organization keen on augmenting healthcare outcomes and is an integral part of Alphabet Inc. (NASDAQ:GOOGL) . The company uses latest scientific and technological advances to solve problems in the health industry.

Per this collaboration, 3M will continue innovating latest health information systems, based on real-world problems faced by the healthcare industry today. This system will also help in protecting privacy and security of health data. It will be designed around 3M’s highly advanced health industry’s methodologies, which are used by federal agencies, hospital associations, and state Medicaid agencies to enhance quality reporting and payment models.

3M and Verily will jointly work to improve population-level health data-sets. These sets will be transformed into vital information so that the participating hospitals, health systems, payers, regulators and strategic partners will be well equipped to evaluate performance, reduce waste and identify areas that impact efficiency, quality and cost. Such collaborations will help improve the company’s offerings in the healthcare space, in-turn positively impacting its top line.

On Sep 6, 2016, 3M acquired Semfinder, a premier developer of semantic coding of medical services. The deal expanded its healthcare portfolio and is likely to enhance its revenues, going forward. The acquisition of Semfinder will help 3M cater to the changing needs of the customers and enable them to develop next-generation solutions for healthcare records coding. The deal will also help the company expand its 3M Encompass System market worldwide.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Maplewood, MN-based 3M employs 90,000 people worldwide, with operations in more than 65 countries. It manufactures over 55,000 products, including adhesives, abrasives, laminates, passive fire protection, dental and orthodontic products, electronic materials, medical products, car-care products (sun films, polish, wax, car shampoo, treatment for the exterior, interior and the under chassis rust protection), electronic circuits, and optical films.

3M currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the industry include Raven Industries Inc. (NASDAQ:RAVN) and Leucadia National Corporation (NYSE:LUK) , both carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Raven has a long-term earnings growth expectation of 10% and is currently trading at a forward P/E of 44.2x. Its share price has increased by approximately 41.3% year to date.

Leucadia National has a long-term earnings growth expectation of 18% and is currently trading at a forward P/E of 96.4x. Its share price has increased by approximately 11.6% year to date.

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>



3M CO (MMM): Free Stock Analysis Report

LEUCADIA NATL (LUK): Free Stock Analysis Report

RAVEN INDS INC (RAVN): Free Stock Analysis Report

ALPHABET INC-A (GOOGL): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.